It’s called SR9009 and it’s being developed at The Scripps Research Institute (TSRI) — and as of right now it’s only effective on lab mice. There’s a strong probability that it will also be effective on humans, but due to the FDA and a little thing called ‘Hippocratic Oath for scientists,’ scientists can’t just hop into human testing as of now.
What we do know (according to The Scripps Research Institute) is when SR9009 is administered to mice, the level of metabolic activity in skeletal muscles increases, which means decrease in fat, a visible increase in muscle size, and even running capacity. TSRI Professor Thomas Burris even mentioned that these lab mice are getting muscles just like an athlete.
The animals actually get muscles like an athlete who has been training. The pattern of gene expression after treatment with SR9009 is that of an oxidative-type muscle— again, just like an athlete.
According to the study, the mice actually had a 50% increase in running capacity after SR9009. We could bore you and describe how SR9009 utilizes the creation of new mitochondria in muscle cells to promote rapid growth through metabolic reactions and that the old mitochondria is actually cleared out by drug — but most of you just want to know how soon Vitor Belfort can get his hands on the stuff. Oh, you MMA fans.
SR9009 is nowhere close to even having a small-scale clinical tests on humans. However you can follow The Scripps Research Institute on their official site for all the scientific updates on the drug that you will probably be using in the next decade. Props to DENV3RtheDESTROY3R for the +100 news tip.
